Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1132 participants.
Also called NCT02937454
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,132 participants
- Sponsor
- Registry
-
NCT02937454 -
2016-001467-36
-
- Other papers using this trial's data
- Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis
- Ferric Carboxymaltose in Iron-Deficient Patients with Hospitalized Heart Failure and Reduced Kidney Function
- Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
- Intravenous ferric carboxymaltose for iron repletion following acute heart failure in patients with and without diabetes: a subgroup analysis of the randomized AFFIRM-AHF trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Argentina, Brazil, Croatia, Georgia, Israel, Italy, Lebanon, Netherlands, Poland, Romania, Singapore, Spain, Sweden, Ukraine, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02937454. Randomized; triple masking; primary purpose treatment. Start 2017-04-03 (actual); primary completion 2020-07-21 (actual). Results posted on 2021-06-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
- Acronym
- Affirm-AHF
- Condition
- Iron Deficiency
- Condition
- Heart Failure
- Intervention (Drug)
- ferric carboxymaltose
- Intervention (Other)
- Normal saline 0.9%
- Lead sponsor
- Vifor (International) Inc.
- Collaborator
- Worldwide Clinical Trials
- Collaborator
- Cytel Inc.
Record details
- Record id
cardio:ct-nct02937454- Content hash
1df1d171ce54d2a21ee499b4f2cc2779caf853400dffbcc7039ed263796ff3c9